TSXV - Delayed Quote CAD
LSL Pharma Group Inc. (LSL.V)
0.3500
+0.0050
+(1.45%)
At close: April 25 at 2:55:53 PM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
9/30/2020
Total Assets
30,900
27,312
29,030.3060
23,787.6830
Total Liabilities Net Minority Interest
22,245
22,021
17,917.4620
16,305.4170
Total Equity Gross Minority Interest
8,655
5,291
11,112.8440
7,482.2660
Total Capitalization
13,388
13,133
19,089.9260
10,990.5850
Common Stock Equity
8,655
5,291
11,112.8440
7,482.2660
Capital Lease Obligations
2,555
2,697
2,872.5730
1,233.4300
Net Tangible Assets
-276
-3,690
1,719.8410
-2,426.0710
Working Capital
-7,870
-7,223
-778.7520
-7,897.6210
Invested Capital
22,369
17,447
20,982.8440
16,818.3230
Tangible Book Value
-276
-3,690
1,719.8410
-2,426.0710
Total Debt
16,269
14,853
12,742.5730
10,569.4870
Net Debt
13,706
12,156
9,128.9900
8,873.9320
Share Issued
82,435.1770
82,226.4350
82,226.4350
82,226.4350
Ordinary Shares Number
82,435.1770
82,226.4350
82,226.4350
82,226.4350
9/30/2020 - 3/2/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade